Michael Goldstein, Director at BioScrip, Inc. (BIOS), bought 50,000 shares at $2.49 ($125K) on 2016-06-17, disclosed to the SEC on 2016-06-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.49 | 25,000 | $62K | 50.0% |
| 2 | $2.49 | 25,000 | $62K | 50.0% |
| Total | $2.49 avg | 50,000 | $125K | 100% |
| Filing → |
| TDOC | SELL | 2020-04-17 | $5.3M | — | Filing → |
| TCX | BUY | 2020-02-27 | $10K | — | Filing → |
| TDOC | SELL | 2019-03-07 | $1.3M | — | Filing → |